Bandaram Pharma Packtech Ltd

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Bandaram Pharma Packtech Ltd. (BSE: 524602), a micro-cap healthcare services company with a market capitalisation of ₹52.00 crores, reported a dramatic revenue acceleration in Q4 FY26 that failed to translate into meaningful bottom-line growth. The company posted a consolidated net profit of ₹0.09 crores for the quarter ended March 2026, representing a sharp 52.63% decline quarter-on-quarter and a 40.00% drop year-on-year, even as net sales surged 76.95% sequentially to ₹26.26 crores. Following the results, the stock traded at ₹28.45 on June 1, 2026, reflecting a 5.33% single-day gain but remaining 42.76% below its 52-week high of ₹49.70.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into its performance and outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date analysis of the company’s standing.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the latest insights into the company’s performance and outlook.

For the fourth consecutive session, Bandaram Pharma Packtech Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 22 on 1 Apr 2026. This marks a steep 20.03% drop over the last four days, underscoring persistent selling pressure despite a broadly positive market backdrop.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Bandaram Pharma Packtech Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating despite lingering concerns over its profitability metrics and market performance. This recalibration in price-to-earnings and price-to-book value ratios invites a closer examination of the stock’s price attractiveness relative to its historical averages and peer group within the healthcare services sector.

Bandaram Pharma Packtech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Bandaram Pharma Packtech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 26 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Bandaram Pharma Packtech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 Dec 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 27 December 2025, providing investors with the latest insights into its performance and outlook.